Cleared Traditional

K213053 - Gold Anchor

K213053 is an FDA 510(k) clearance for Gold Anchor, manufactured by Naslund Medical AB. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 106-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
106d
Days
Class 2
Risk

K213053 is an FDA 510(k) clearance for the Gold Anchor. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Naslund Medical AB (Huddinge, SE). The FDA issued a Cleared decision on January 6, 2022 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Naslund Medical AB devices

FDA 510(k) Submission Details - K213053

510(k) Number K213053 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2021
Decision Date January 06, 2022
Days to Decision 106 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 107d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 333
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K213053.
Aurora-RT
K213526 · Magnettx Oncology Solutions , Ltd. · May 2022
ExacTrac Dynamic
K220338 · Brainlab AG · Apr 2022
VERIQA
K213370 · Ptw-Freiburg Physikalisch-Technische-Werkstaetten · Mar 2022
MRIdian Linac System
K212958 · Viewray, Incorporated · Dec 2021
AlignRT Plus
K212583 · Vision Rt, Ltd. · Nov 2021
TaiChiB
K210921 · Our United Corporation · Nov 2021